Reteplase biosimilar (Reliance Life Sciences) | Interleukin Related interleukin-related.com

Product Name :
Reteplase biosimilar (Reliance Life Sciences)

Search keywords :
Reteplase

drugId :
null

Target Vo:
Plasminogen

Target Vo Short Name :
PLG

Moa_Name:
Plasminogen stimulants

First Approval Country :
India

First Approval Date Filter:
2009

Origin Company_Name :
Reliance Life Sciences

Active Company_Name :
Reliance Life Sciences

Active Indication_Name:
Myocardial Infarction

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
ABCG2 Rabbit mAb Technical Information
Lutikizumab Description
RhoA/B/C Antibody: RhoA/B/C Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 22 kDa, targeting to RhoA/B/C. It can be used for WB,IHC-P,ICC/IF,FC assays with tag free, in the background of Human, Mouse, Rat.

Author: Interleukin Related

Related Posts